Immatics IMTX
NASDAQ IMTX
$6.70 +0.28 (+4.36%)
As of: Nov 11, 2026 · 3:59 PM EST

Immatics (IMTX) Net Income Attributable to Noncontrolling Interests (2019 - 2020)

Updated

Immatics' Net Income Attributable to Noncontrolling Interests was -$635,968 in FY2020, compared with -$1.03 million in FY2019.

Analysis

Immatics (IMTX) Net Income Attributable to Noncontrolling Interests (2019 - 2020) Analysis & Trends

  • Per Business Quant data, Net Income Attributable to Noncontrolling Interests in earlier years was -$1.03 million in FY2019 and -$1.08 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 10.00 Mn
10 Immatics 860.74 Mn -1.20 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 -311,713.22
Mar 31, 2020 -302,479.29
Dec 31, 2019 -249,049.73
Sep 30, 2019 -291,535.27
Jun 30, 2019 -260,684.27
API Access

Immatics Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=IMTX&period=max&api_key=YOUR_API_KEY